Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3β-mediated phosphorylation of β-catenin

被引:0
|
作者
K Haraguchi
M Ohsugi
Y Abe
K Semba
T Akiyama
T Yamamoto
机构
[1] Institute of Medical Science,Division of Oncology
[2] University of Tokyo,Division of Cellular and Molecular Biology
[3] Institute of Medical Science,undefined
[4] University of Tokyo,undefined
[5] Laboratory of Molecular and Genetic Information,undefined
[6] Institute of Molecular and Cellular Bioscience,undefined
[7] University of Tokyo,undefined
[8] 4Current address: Department of Molecular Biology,undefined
[9] Institute of Gerontology,undefined
[10] Nippon Medical School,undefined
[11] Kawasaki 211-8533,undefined
[12] Japan.,undefined
来源
Oncogene | 2008年 / 27卷
关键词
Wnt; -catenin; GSK-3; Ajuba; phosphorylation;
D O I
暂无
中图分类号
学科分类号
摘要
The Wnt signaling pathway is essential for embryonic development and carcinogenesis. Upon Wnt stimulation, β-catenin is stabilized and associates with T-cell factor or lymphoid enhancing factor, thereby activating transcription of target genes. In the absence of Wnt stimulation, the level of β-catenin is reduced via glycogen synthase kinase (GSK)-3β-mediated phosphorylation and subsequent proteasome-dependent degradation. Here, we report the identification of Ajuba as a negative regulator of the Wnt signaling pathway. Ajuba is a member of LIM domain-containing proteins that contribute to cell fate determination and regulate cell proliferation and differentiation. We found that enforced expression of Ajuba destabilized β-catenin and suppressed target gene expression. Ajuba promoted GSK-3β-mediated phosphorylation of β-catenin by reinforcing the association between β-catenin and GSK-3β. Furthermore, Wnt stimulation induced both accumulation of β-catenin and destabilization of Ajuba. Our findings suggest that Ajuba is important for regulation of the Wnt signaling pathway.
引用
收藏
页码:274 / 284
页数:10
相关论文
共 50 条
  • [31] GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma
    Ban, KC
    Singh, H
    Krishnan, R
    Seow, HF
    CANCER LETTERS, 2003, 199 (02) : 201 - 208
  • [32] GSK-3β negatively regulates skeletal myotube hypertrophy
    Vyas, DR
    Spangenburg, EE
    Abraha, TW
    Childs, TE
    Booth, FW
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 283 (02): : C545 - C551
  • [33] Proposed hypothesis of GSK-3 β inhibition for stimulating Wnt/β-catenin signaling pathway which triggers liver regeneration process
    Chirag Khurana
    Onkar Bedi
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 377 - 380
  • [34] Proposed hypothesis of GSK-3β inhibition for stimulating Wnt/β-catenin signaling pathway which triggers liver regeneration process
    Khurana, Chirag
    Bedi, Onkar
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (03) : 377 - 380
  • [35] Inhibitory Gli3 activity negatively regulates Wnt/β-catenin signaling
    Ulloa, Fausto
    Itasaki, Nobue
    Briscoe, James
    CURRENT BIOLOGY, 2007, 17 (06) : 545 - 550
  • [36] Inhibition of GSK-3β ameliorates hepatic ischemia-reperfusion injury through GSK-3β/β-catenin signaling pathway in mice
    Xia, Yong-Xiang
    Lu, Ling
    Wu, Zheng-Shan
    Pu, Li-Yong
    Sun, Bei-Cheng
    Wang, Xue-Hao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (03) : 278 - 284
  • [38] NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling
    Masoumi, Katarzyna Chmielarska
    Daams, Renee
    Sime, Wondossen
    Siino, Valentina
    Ke, Hengning
    Levander, Fredrik
    Massoumi, Ramin
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28 (02) : 346 - 355
  • [39] 20(S)-protopanaxadiol promotes the migration, proliferation, and differentiation of neural stem cells by targeting GSK-3β in the Wnt/ GSK-3β/β-catenin pathway
    Lin, Kaili
    Liu, Bin
    Lim, Sze-Lam
    Fu, Xiuqiong
    Sze, Stephen C-W
    Yung, Ken K-L
    Zhang, Shiqing
    JOURNAL OF GINSENG RESEARCH, 2020, 44 (03) : 475 - 482
  • [40] Role of GSK-3β in Regulation of Canonical Wnt/β-catenin Signaling and PI3-K/Akt Oncogenic Pathway in Colon Cancer
    Jain, Shelly
    Ghanghas, Preety
    Rana, Chandan
    Sanyal, S. N.
    CANCER INVESTIGATION, 2017, 35 (07) : 473 - 483